Efficacy and safety of fixed-dose combinations of aclidinium bromide/formoterol fumarate: the 24-week, randomized, placebo-controlled AUGMENT COPD study

被引:0
作者
Anthony D D’Urzo
Stephen I Rennard
Edward M Kerwin
Victor Mergel
Anne R Leselbaum
Cynthia F Caracta
机构
[1] University of Toronto,
[2] University of Nebraska Medical Center,undefined
[3] Clinical Research Institute,undefined
[4] Forest Research Institute,undefined
[5] R&D Centre,undefined
[6] Almirall,undefined
[7] the AUGMENT COPD study investigators,undefined
来源
Respiratory Research | / 15卷
关键词
Aclidinium; Formoterol; COPD; Lung function; Dyspnea; Health status;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 240 条
[1]  
Rabe KF(2008)Comparison of a combination of tiotropium plus formoterol to salmeterol plus fluticasone in moderate COPD Chest 134 255-262
[2]  
Timmer W(2005)Comparison of tiotropium once daily, formoterol twice daily and both combined once daily in patients with COPD Eur Respir J 26 214-222
[3]  
Sagkriotis A(2011)Comparison of tiotropium plus formoterol to tiotropium alone in stable chronic obstructive pulmonary disease: a meta-analysis Respirology 16 350-358
[4]  
Viel K(2012)Concurrent use of indacaterol plus tiotropium in patients with COPD provides superior bronchodilation compared with tiotropium alone: a randomised, double-blind comparison Thorax 67 781-788
[5]  
van Noord JA(2006)Effects of tiotropium with and without formoterol on airflow obstruction and resting hyperinflation in patients with COPD Chest 129 509-517
[6]  
Aumann JL(2013)One-year extension study of ACCORD COPD I: safety and efficacy of two doses of twice-daily aclidinium bromide in patients with COPD COPD 10 500-510
[7]  
Janssens E(2012)Efficacy of aclidinium bromide 400 μg twice daily compared with placebo and tiotropium in patients with moderate to severe COPD Chest 141 745-752
[8]  
Smeets JJ(2013)Long-term safety and efficacy of twice-daily aclidinium bromide in patients with COPD Respir Med 107 1957-1965
[9]  
Verhaert J(2012)Efficacy and safety of twice-daily aclidinium bromide in COPD patients: the ATTAIN study Eur Respir J 40 830-836
[10]  
Disse B(2012)Efficacy and safety of a 12-week treatment with twice-daily aclidinium bromide in COPD patients (ACCORD COPD I) COPD 9 90-101